I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 3 CLEAR study in patients with advanced renal cell ca..:
Viktor Grünwald
;
Thomas Powles
;
Masatoshi Eto
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1223282/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1223282
RT Journal T1
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:09be4e69130a41858b234cdb2b5887cc&Exemplar=1&LAN=DE A1 Viktor Grünwald A1 Thomas Powles A1 Masatoshi Eto A1 Evgeny Kopyltsov A1 Sun Young Rha A1 Camillo Porta A1 Robert Motzer A1 Thomas E. Hutson A1 María José Méndez-Vidal A1 Sung-Hoo Hong A1 Eric Winquist A1 Jeffrey C. Goh A1 Pablo Maroto A1 Tomas Buchler A1 Toshio Takagi A1 Joseph E. Burgents A1 Rodolfo Perini A1 Cixin He A1 Chinyere E. Okpara A1 Jodi McKenzie A1 Toni K. Choueiri PB Frontiers Media S.A. YR 2023 K1 renal cell carcinoma K1 lenvatinib K1 pembrolizumab K1 sunitinib K1 bone metastases K1 liver metastases K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1223282/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1223282 DO https://doi.org/10.3389/fonc.2023.1223282 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)